Literature DB >> 10678631

Venous and arterial changes in pulmonary veno-occlusive disease, mitral stenosis and fibrosing mediastinitis.

I Chazova1, I Robbins, J Loyd, J Newman, V Tapson, V Zhdaov, B Meyrick.   

Abstract

The pathogenesis of pulmonary veno-occlusive disease (PVOD) is not known. The diagnosis of PVOD frequently relies on its histological changes since it is often difficult to distinguish clinically from primary pulmonary hypertension. This study carried out a systematic analysis of the pulmonary venous and arterial remodelling that occurs in PVOD (n=5) and compared these changes to two other diseases affecting the pulmonary veins, mitral stenosis (MS; n=6) and fibrosing mediastinitis (FM; n=2), using established morphometric techniques. In PVOD, pronounced intimal and adventitial thickening were noted in veins of all sizes and arterialization of veins >50 microm external diameter was found. Similar changes were evident in the arterial wall, but intimal thickening was less severe than in the veins and medial thickening was more pronounced in arteries <300 microm external diameter. Eccentric intimal fibrosis of the veins was also noted for the first time in PVOD, although this feature occurred less frequently (approximately one third) than in MS. Less pronounced structural remodelling was also encountered in the veins in cases of MS and FM. The severity of the venous changes in PVOD may aid its diagnosis and lend insight into its pathogenesis. However, the similarity of the vascular changes in each form of venous hypertension also suggests that pathology alone may not always differentiate between these disease states. The similarity of the vascular changes in the three forms of venous hypertension suggests that, as in pulmonary artery hypertension, pressure, per se, is one of the triggers to vascular remodelling.

Entities:  

Mesh:

Year:  2000        PMID: 10678631     DOI: 10.1183/09031936.00.15111600

Source DB:  PubMed          Journal:  Eur Respir J        ISSN: 0903-1936            Impact factor:   16.671


  9 in total

1.  Use of pulmonary arterial hypertension-approved therapy in the treatment of non-group 1 pulmonary hypertension at US referral centers.

Authors:  Aaron W Trammell; Meredith E Pugh; John H Newman; Anna R Hemnes; Ivan M Robbins
Journal:  Pulm Circ       Date:  2015-06       Impact factor: 3.017

2.  Pulmonary hypertension associated with sarcoidosis: mechanisms, haemodynamics and prognosis.

Authors:  H Nunes; M Humbert; F Capron; M Brauner; O Sitbon; J-P Battesti; G Simonneau; D Valeyre
Journal:  Thorax       Date:  2005-10-14       Impact factor: 9.139

Review 3.  The State of the Art in Pulmonary Vein Stenosis -Diagnosis & Treatment.

Authors:  Lourdes R Prieto
Journal:  J Atr Fibrillation       Date:  2010-01-01

4.  Pulmonary hypertension associated with lung transplantation obliterative bronchiolitis and vascular remodeling of the allograft.

Authors:  R Saggar; D J Ross; R Saggar; D A Zisman; A Gregson; J P Lynch; M P Keane; S Samuel Weigt; A Ardehali; B Kubak; C Lai; D Elashoff; M C Fishbein; W D Wallace; J A Belperio
Journal:  Am J Transplant       Date:  2008-07-28       Impact factor: 8.086

Review 5.  [Acute and chronic mediastinitis].

Authors:  J Kluge
Journal:  Chirurg       Date:  2016-06       Impact factor: 0.955

6.  Global Pulmonary Vascular Remodeling in Pulmonary Hypertension Associated With Heart Failure and Preserved or Reduced Ejection Fraction.

Authors:  Ahmed U Fayyaz; William D Edwards; Joseph J Maleszewski; Ewa A Konik; Hilary M DuBrock; Barry A Borlaug; Robert P Frantz; Sarah M Jenkins; Margaret M Redfield
Journal:  Circulation       Date:  2017-12-15       Impact factor: 29.690

7.  Refractory pleural effusion as a rare complication of pulmonary vascular stenosis induced by fibrosing mediastinitis: a case report and literature review.

Authors:  Suqiao Yang; Jianfeng Wang; Jifeng Li; Kewu Huang; Yuanhua Yang
Journal:  J Int Med Res       Date:  2021-05       Impact factor: 1.671

8.  Catheter-based intervention for pulmonary vein stenosis due to fibrosing mediastinitis: The Mayo Clinic experience.

Authors:  Shiva P Ponamgi; Christopher V DeSimone; Charles J Lenz; Megan Coylewright; Samuel J Asirvatham; David R Holmes; Douglas L Packer
Journal:  Int J Cardiol Heart Vasc       Date:  2015-06-18

Review 9.  Fibrosing mediastinitis with pulmonary hypertension as a complication of pulmonary vein stenosis: A case report and review of the literature.

Authors:  Yidan Li; Xiangli Meng; Yidan Wang; Yuanhua Yang; Xiuzhang Lu
Journal:  Medicine (Baltimore)       Date:  2018-01       Impact factor: 1.889

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.